Keywords
novel effects
treatment
drug development
Abstract
Ketoprofen (K) belongs to the family of nonsteroidal anti-inflammatory drugs (NSAIDs) and demonstrates analgesic, anti-inflammatory and antipyretic properties. K is one of the most commonly used NSAIDs because of the speed and effectiveness of its activity. K is currently used for the treatment of pain and treatment of symptoms in rheumatic diseases, however, many researchers are looking for new uses of K. The aim of the review was to present the possible applications of K as indicated in current literature. We searched research literature and compiled all the reports (2015 onwards) we could find about new possible employments of K in health practices. Many studies have been aimed at obtaining new uses of K. This article describes the use of ketoprofen lysine salt for treating injured gastric mucosa, the anti-allergic potential of K, the employment of K in treating nonalcoholic fatty liver disease, human lymphedema and seizures, as well as the antidepressant and anxiolytic effects of K, prospects for the use of K in oncology and transplantology. The findings of the review confirm that K, its derivatives and complexes have many newly discovered effects. It is likely that in the future, K will have more indications than it has today.References
1. Chawla G, Ranjan C, Kumar J, Siddiqui AA. Chemical modifications of ketoprofen (NSAID) in search of better lead compounds: A Review of literature from 2004-2016. Antiinflamm Antiallergy Agents Med Chem. 2017;15(3):154-77.
2. Kuczyńska J, Nieradko-Iwanicka B. Future prospects of ketoprofen in improving the safety of the gastric mucosa. Biomed Pharmacother. 2021;139:111608.
3. Patrignani P, Patrono C. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs. Biochim Biophys Acta. 2015; 1851(4):422-32.
4. Kayipmaz AE, Giray TA, Tasci SS, Tasci SS, Kavalci C, Kocalar UG. Acute dystonic reaction due to dexketoprofen trometamol. J Pak Med Assoc. 2015;65(11):1231-2.
5. Kuczyńska J, Nieradko-Iwanicka B. The effect of ketoprofen lysine salt on mucosa of rat stomach after ethyl alcohol intoxication. Biomed Pharmacother. 2021;141:111938.
6. Cheng YT, Lin JA, Jhang JJ, Yen GC. Protocatechuic acid-mediated DJ-1/PARK7 activation followed by PI3K/mTOR signaling pathway activation as a novel mechanism for protection against ketoprofen-induced oxidative damage in the gastrointestinal mucosa. Free Radic Biol Med. 2019;130:35-47.
7. Pereira-Leite C, Nunes C, Jamal SK, Cuccovia IM, Reis S. Nonsteroidal anti-inflammatory therapy: A journey toward safety. Med Res Rev. 2017;37(4):802-59.
8. Wang J, Zhao SQ, Zhang MY, He BS. Targeted eco-pharmacovigilance for ketoprofen in the environment: Need, strategy and challenge. Chemosphere. 2018;194:450-462.
9. Rafanan BS Jr, Valdecañas BF, Lim BP, Malairungsakul A, Tassanawipas W, Shiyi C, et al. Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-Pacific. Pain Manag. 2018;8(2):115-28.
10. Ketoprofen, Summary of Product Characteristics. [https://bazalekow.mp.pl/leki/doctor_subst.html?id=444] (accessed 19 March 2022).
11. Cerciello A, Auriemma G, Del Gaudio P, Cantarini M, Aquino RP. Natural polysaccharides platforms for oral controlled release of ketoprofen lysine salt. Drug Dev Ind Pharm. 2016;42(12):2063-9.
12. Cimini A, Brandolini L, Gentile R, Cristiano L, Menghini P, Fidoamore A, et al. Gastroprotective effects of L-lysine salification of ketoprofen in ethanol-injured gastric mucosa. J Cell Physiol. 2015; 230(4):813-20.
13. Brandolini L, d'Angelo M, Antonosante A, Villa S, Cristiano L, Castelli V, et al. Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium. J Cell Physiol. 2018;233(3):2304-12.
14. Gemici B, Elsheikh W, Feitosa KB, Costa SK, Muscara MN, Wallace JL. H2S-releasing drugs: Anti-inflammatory, cytoprotective and chemopreventative potential. Nitric Oxide. 2015;46:25-31.
15. Seuanes GC, Moreira MB, Petta T, de Moraes Del Lama MPF, de Moraes LAB, de Oliveira ARM, et al. Novel binuclear μ-oxo diruthenium complexes combined with ibuprofen and ketoprofen: Interaction with relevant target biomolecules and anti-allergic potential. J Inorg Biochem. 2015;153:178-85.
16. Wang Z, Ma C, Shang Y, Yang L, Zhang J, Yang C, et al. Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD). Chem Commun (Camb). 2020;56(36):4922-5.
17. Tian W, Rockson SG, Jiang X, Kim J, Begaye A, Shuffle EM, et al. Leukotriene B4 antagonism ameliorates experimental lymphedema. Sci Transl Med. 2017;9(389):eaal3920.
18. Rockson SG, Tian W, Jiang X, Kuznetsova T, Haddad F, Zampell J, et al. Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema. JCI Insight. 2018; 3(20):e123775.
19. Erbaş O, Solmaz V, Aksoy D. Inhibitor effect of dexketoprofen in rat model of pentylenetetrazol-induced seizures. Neurol Res. 2015;37(12): 1096-101.
20. Makunts T, Cohen IV, Lee KC, Abagyan R. Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain. PLoS One. 2018;13(4):e0195521.
21. Ravera M, Zanellato I, Gabano E, Perin E, Rangone B, Coppola M, et al. Antiproliferative activity of Pt(IV) conjugates containing the non-steroidal anti-inflammatory drugs (NSAIDs) ketoprofen and Nnproxen. Int J Mol Sci. 2019;20(12):3074.
22. Yu T, Lao X, Zheng H. Influencing COX-2 Activity by COX related pathways in inflammation and cancer. Mini Rev Med Chem. 2016; 16(15):1230-43.
23. Çoban Ö, Değim Z, Yılmaz Ş, Altıntaş L, Arsoy T, Sözmen M. Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. Drug Dev Res. 2019;80(5):556-65.
24. Ferreira LM, Cervi VF, Gehrcke M, da Silveira EF, Azambuja JH, Braganhol E, et al. Ketoprofen-loaded pomegranate seed oil nanoemulsion stabilized by pullulan: Selective antiglioma formulation for intravenous administration. Colloids Surf B Biointerfaces. 2015;130:272-7.
25. Noverraz F, Montanari E, Pimenta J, Szabó L, Ortiz D, Gonelle-Gispert C, et al. Antifibrotic effect of ketoprofen-grafted alginate microcapsules in the transplantation of insulin producing cells. Bioconjug Chem. 2018;29(6):1932-41.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2022 Authors